Phase II study of oral temozolomide (TMZ) in children with progressive low-grade gliomas (LGG)

被引：0
|
作者：
Gururangan, S [1 ]
Allen, JC [1 ]
Phillips, PC [1 ]
Dillard, E [1 ]
Friedman, HS [1 ]
机构：
[1] Duke Univ, Med Ctr, Brain Tumor Ctr, Durham, NC USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [41] A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma
    Wright, Karen D.
    Yao, Xiaopan
    London, Wendy B.
    Kao, Pei-Chi
    Gore, Lia
    Hunger, Stephen
    Geyer, Russ
    Cohen, Kenneth J.
    Allen, Jeffrey C.
    Katzenstein, Howard M.
    Smith, Amy
    Boklan, Jessica
    Nazemi, Kellie
    Trippett, Tanya
    Karajannis, Matthias
    Herzog, Cynthia
    Destefano, Joseph
    Direnzo, Jennifer
    Pietrantonio, Jay
    Greenspan, Lianne
    Cassidy, Danielle
    Schissel, Debra
    Perentesis, John
    Basu, Mitali
    Mizuno, Tomoyuki
    Vinks, Alexander A.
    Prabhu, Sanjay P.
    Chi, Susan N.
    Kieran, Mark W.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (02)
  • [42] Phase II study of weekly vinblastine in recurrent/refractory pediatric low-grade gliomas
    Bouffet, Eric
    Jakacki, Regina
    Goldman, Stewart
    Hargrave, Darren
    Shroff, Manohar
    Hukin, Juliette
    Bartels, Ute
    Farley, Shannon
    Baruchel, Sylvain
    NEURO-ONCOLOGY, 2008, 10 (03) : 450 - 450
  • [43] Impact of repeated operations for progressive low-grade gliomas
    Shofty, Ben
    Haim, Oz
    Costa, Matias
    Kashanian, Alon
    Shtrozberg, Shai
    Ram, Zvi
    Grossman, Rachel
    EJSO, 2020, 46 (12): : 2331 - 2337
  • [44] Phase II trial of sunitinib malate and lomustine in patients with temozolomide refractory recurrent low-grade and anaplastic gliomas.
    Duerinck, Johnny
    Du Four, Stephanie
    Van Binst, An
    Everaert, Hendrik
    Michotte, Alex
    D'haens, Jean
    Neyns, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY
    Fangusaro, Jason
    Onar-Thomas, Arzu
    Poussaint, Tina Y.
    Wu, Shengjie
    Ligon, Azra H.
    Lindeman, Neal
    Banerjee, Anu
    Packer, Roger J.
    Kilburn, Lindsay B.
    Pollack, Ian F.
    Jakacki, Regina I.
    Qaddoumi, Ibrahim
    Fisher, Paul G.
    Dhall, Girish
    Baxter, Patricia
    Kreissman, Susan G.
    Stewart, Clinton F.
    Pfister, Stefan M.
    Jones, David T. W.
    Vezina, Gilbert
    Stern, Jessica
    Panigrahy, Ashok
    Jones, Blaise V.
    Patay, Zoltan
    Tamrazi, Benita
    Jones, Jeremy Y.
    Haque, Sofia S.
    Enterline, David S.
    Cha, Soonmee
    Doyle, Laurence A.
    Smith, Malcolm
    Boyett, James M.
    Dunkel, Ira J.
    Fouladi, Maryam
    NEURO-ONCOLOGY, 2017, 19 : 34 - 35
  • [46] Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas
    Brada, M
    Viviers, L
    Abson, C
    Hines, F
    Britton, J
    Ashley, S
    Sardell, S
    Traish, D
    Gonsalves, A
    Wilkins, P
    Westbury, C
    ANNALS OF ONCOLOGY, 2003, 14 (12) : 1715 - 1721
  • [47] A phase II study of temozolomide in the treatment of adult patients with supratentorial low-grade glioma.
    Wahl, Michael Traut
    Aicardi, Jonathan
    Haas-Kogan, Daphne A.
    Butowski, Nicholas A.
    Clarke, Jennifer Leigh
    Prados, Michael
    Phillips, Joanna J.
    Berger, Mitchel S.
    Chang, Susan Marina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] The toxicity and efficacy of protracted low-dose temozolomide for low-grade gliomas
    Pouratian, Nader
    Gasco, Jaime
    Shaffrey, Mark
    Schiff, David
    NEURO-ONCOLOGY, 2006, 8 (04) : 450 - 450
  • [49] Phase II study of concurrent continuous Temozolomide (TMZ) and Tamoxifen (TMX) for recurrent malignant astrocytic gliomas
    Spence, AM
    Peterson, RA
    Scharnhorst, JD
    Silbergeld, DL
    Rostomily, RC
    JOURNAL OF NEURO-ONCOLOGY, 2004, 70 (01) : 91 - 95
  • [50] Phase II Study of Concurrent Continuous Temozolomide (TMZ) and Tamoxifen (TMX) for Recurrent Malignant Astrocytic Gliomas
    Alexander M. Spence
    Richard A. Peterson
    Jeffrey D. Scharnhorst
    Daniel L. Silbergeld
    Robert C. Rostomily
    Journal of Neuro-Oncology, 2004, 70 : 91 - 95
12345